(−)-Hyoscyamine |
A muscarinic receptor antagonist; an isomer of atropine; inhibits the arte… |
1 g |
25644-1 |
More Info
|
(−)-Hyoscyamine |
A muscarinic receptor antagonist; an isomer of atropine; inhibits the arte… |
250 mg |
25644-250 |
More Info
|
(−)-Hyoscyamine |
A muscarinic receptor antagonist; an isomer of atropine; inhibits the arte… |
5 g |
25644-5 |
More Info
|
(−)-Hyoscyamine |
A muscarinic receptor antagonist; an isomer of atropine; inhibits the arte… |
500 mg |
25644-500 |
More Info
|
(−)-Hyoscyamine-d3 |
An internal standard for the quantification of (-)-hyoscyamine by GC- or L… |
5 mg |
26760-5 |
More Info
|
(−)-Indolactam V |
A tumor-promoting teleocidin compound that activates PKC (Ki = 3.4 nM and… |
1 mg |
14647-1 |
More Info
|
(−)-Indolactam V |
A tumor-promoting teleocidin compound that activates PKC (Ki = 3.4 nM and… |
500 µg |
14647-500 |
More Info
|
(−)-Isocorypalmine |
An isoquinoline alkaloid and metabolite of L-THP with diverse biological a… |
1 mg |
29886-1 |
More Info
|
(−)-Isocorypalmine |
An isoquinoline alkaloid and metabolite of L-THP with diverse biological a… |
5 mg |
29886-5 |
More Info
|
(−)-Isopulegol |
A monoterpene with diverse biological activities; antibacterial activity a… |
100 g |
23161-100 |
More Info
|
(−)-Isopulegol |
A monoterpene with diverse biological activities; antibacterial activity a… |
25 g |
23161-25 |
More Info
|
(−)-Isopulegol |
A monoterpene with diverse biological activities; antibacterial activity a… |
250 g |
23161-250 |
More Info
|
(−)-Isopulegol |
A monoterpene with diverse biological activities; antibacterial activity a… |
50 g |
23161-50 |
More Info
|
(−)-Isoxanthohumol |
An enantiomer of isoxanthohumol; found in similar amounts as (+)-isoxantho… |
1 mg |
25105-1 |
More Info
|
(−)-Isoxanthohumol |
An enantiomer of isoxanthohumol; found in similar amounts as (+)-isoxantho… |
10 mg |
25105-10 |
More Info
|
(−)-Isoxanthohumol |
An enantiomer of isoxanthohumol; found in similar amounts as (+)-isoxantho… |
5 mg |
25105-5 |
More Info
|
(−)-JQ1 |
The inactive stereoisomer of a selective BET bromodomain inhibitor |
1 mg |
11232-1 |
More Info
|
(−)-JQ1 |
The inactive stereoisomer of a selective BET bromodomain inhibitor |
10 mg |
11232-10 |
More Info
|
(−)-JQ1 |
The inactive stereoisomer of a selective BET bromodomain inhibitor |
25 mg |
11232-25 |
More Info
|
(−)-JQ1 |
The inactive stereoisomer of a selective BET bromodomain inhibitor |
5 mg |
11232-5 |
More Info
|
(−)-Levamisole |
An analytical reference standard categorized as an imidazothiazole; used a… |
1 mg |
33972-1 |
More Info
|
(−)-Levamisole |
An analytical reference standard categorized as an imidazothiazole; used a… |
5 mg |
33972-5 |
More Info
|
(−)-L-threo-PDMP (hydrochloride) |
An enhancer of ganglioside biosynthesis; increases glucosylceramide syntha… |
1 mg |
10005278-1 |
More Info
|
(−)-L-threo-PDMP (hydrochloride) |
An enhancer of ganglioside biosynthesis; increases glucosylceramide syntha… |
10 mg |
10005278-10 |
More Info
|
(−)-L-threo-PDMP (hydrochloride) |
An enhancer of ganglioside biosynthesis; increases glucosylceramide syntha… |
5 mg |
10005278-5 |
More Info
|
(−)-3,4-Methylenedioxy Pyrovalerone (hydrochloride) |
An enantiomerically pure isomer of 3,4-MDPV; regulated as a Schedule 1 com… |
1 mg |
14525-1 |
More Info
|
(−)-3,4-Methylenedioxy Pyrovalerone (hydrochloride) |
An enantiomerically pure isomer of 3,4-MDPV; regulated as a Schedule 1 com… |
10 mg |
14525-10 |
More Info
|
(−)-3,4-Methylenedioxy Pyrovalerone (hydrochloride) |
An enantiomerically pure isomer of 3,4-MDPV; regulated as a Schedule 1 com… |
5 mg |
14525-5 |
More Info
|
(−)-MK-801 (maleate) |
An NMDA receptor antagonist (Ki = 43 nM for inhibition of spermine binding… |
10 mg |
27213-10 |
More Info
|
(−)-MK-801 (maleate) |
An NMDA receptor antagonist (Ki = 43 nM for inhibition of spermine binding… |
25 mg |
27213-25 |
More Info
|
(−)-MK-801 (maleate) |
An NMDA receptor antagonist (Ki = 43 nM for inhibition of spermine binding… |
5 mg |
27213-5 |
More Info
|
(−)-MK-801 (maleate) |
An NMDA receptor antagonist (Ki = 43 nM for inhibition of spermine binding… |
50 mg |
27213-50 |
More Info
|
(−)-Narwedine |
An alkaloid with enzyme inhibitory activity; an inhibitor of AChE, BChE, a… |
1 mg |
40744-1 |
More Info
|
(−)-Narwedine |
An alkaloid with enzyme inhibitory activity; an inhibitor of AChE, BChE, a… |
10 mg |
40744-10 |
More Info
|
(−)-Narwedine |
An alkaloid with enzyme inhibitory activity; an inhibitor of AChE, BChE, a… |
25 mg |
40744-25 |
More Info
|
(−)-Narwedine |
An alkaloid with enzyme inhibitory activity; an inhibitor of AChE, BChE, a… |
5 mg |
40744-5 |
More Info
|
(−)-Nicotine |
An alkaloid; an agonist at neuronal nAChRs; binds to α3β4 and &… |
10 g |
29138-10 |
More Info
|
(−)-Nicotine |
An alkaloid; an agonist at neuronal nAChRs; binds to α3β4 and &… |
25 g |
29138-25 |
More Info
|
(−)-Nicotine (tartrate) |
The dominant form of natural nicotine; an agonist of nAChRs |
1 g |
20887-1 |
More Info
|
(−)-Nicotine (tartrate) |
The dominant form of natural nicotine; an agonist of nAChRs |
10 g |
20887-10 |
More Info
|
(−)-Nicotine (tartrate) |
The dominant form of natural nicotine; an agonist of nAChRs |
5 g |
20887-5 |
More Info
|
(−)-Nicotine (tartrate) |
The dominant form of natural nicotine; an agonist of nAChRs |
500 mg |
20887-500 |
More Info
|
(−)-7-nor-7-carboxy Cannabidiol |
An analytical reference standard categorized as a phytocannabinoid metabol… |
1 mg |
21637-1 |
More Info
|
(−)-7-nor-7-carboxy Cannabidiol |
An analytical reference standard categorized as a phytocannabinoid metabol… |
5 mg |
21637-5 |
More Info
|
(−)-11-nor-9-carboxy-Δ8-Tetrahydrocannabivarin |
An analytical reference standard that is structurally similar to known phy… |
1 mg |
36631-1 |
More Info
|
(−)-11-nor-9-carboxy-Δ8-Tetrahydrocannabivarin |
An analytical reference standard that is structurally similar to known phy… |
5 mg |
36631-5 |
More Info
|
(−)-11-nor-9-carboxy-Δ8-THC |
An analytical reference standard categorized as a phytocannabinoid metabol… |
1 mg |
25270-1 |
More Info
|
(−)-11-nor-9-carboxy-Δ8-THC |
An analytical reference standard categorized as a phytocannabinoid metabol… |
5 mg |
25270-5 |
More Info
|
(−)-11-nor-9-carboxy-Δ8-THC-d3 |
An internal standard for the quantification of (−)-11-nor-9-carboxy-… |
1 mg |
37041-1 |
More Info
|
(−)-11-nor-9-carboxy-Δ8-THC-d3 |
An internal standard for the quantification of (−)-11-nor-9-carboxy-… |
500 µg |
37041-500 |
More Info
|